Resveratrol Alters Sphingolipid Metabolism in ras-transformed 3T3 Fibroblasts

Authors

  • Albena Momchilova Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
  • Galya Staneva Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
  • Stefan Pankov Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
  • Nikolai Krastev Department of Anatomy, Histology and Embryology Medical University – Sofia, Bulgaria
  • Tania Markovska Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
  • Evgenia Vassileva Clinic of Neurology, University Hospital Tsaritsa Yoanna – ISUL, Bulgaria
  • Biliana Nikolova Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences
  • Dimo Krastev Medical College “Y. Filaretova”, Medical University – Sofia, Bulgaria
  • Roumen Pankov Faculty of Biology, Sofia University “St. Kliment Ohridski”, Bulgaria

DOI:

https://doi.org/10.7546/CRABS.2022.09.08

Keywords:

resveratrol, sphingomyelin, ceramide, sphingosine, sphingosine-1-phosphate

Abstract

The effect of resveratrol on the sphingolipid metabolism has been investigated in ras-transformed 3T3 fibroblasts. Resveratrol is a phytoalexin of a great medico-biological significance, which has been reported to exhibit significant beneficial effects such as antioxidant, lipid-lowering, anti-neoplastic, etc. Sphingolipids are functionally active lipid molecules, which are implicated in important cellular processes, such as proliferation, migration, apoptosis and transmembrane signalling, among others. Although there are many investigations devoted to the influence of resveratrol on the lipid metabolism of various types of cancer cells, the mechanism of this effect on the sphingolipid pathway remains unclear. The present studies showed that the major sphingolipid, sphingomyelin, was decreased in membranes from resveratrol-treated ras-transformed 3T3 fibroblasts, whereas ceramide, which is a pro-apoptotic factor, was elevated due to neutral sphingomyelinase up-regulation. In addition, the level of sphingosine, a product of ceramidase, was increased and the content of sphingosine-1-phosphate, which is related to cell proliferation, was lowered due to resveratrol treatment, which is an important finding especially for cancer cells. The balancing enzyme in the sphingolipid pathway, sphingosine kinase, which produces sphingosine-1-phosphate, was down-regulated in resveratrol-treated oncogene-transformed fibroblasts. In conclusion, the present results clearly show that treatment of ras-transformed fibroblasts with resveratrol induces changes in the major representatives of the sphingolipid metabolic pathway shifting the “sphingolipid rheostat” towards prevalence of the proapoptotic factor ceramide. The reported observations can be applied in the development of complex anti-tumour therapeutic strategies.

Author Biographies

Albena Momchilova, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biophysics
and Biomedical Engineering,
Bulgarian Academy of Sciences
Akad. G. Bonchev St, Bl. 21
1113 Sofia, Bulgaria

Е-mail: albena_momchilova@abv.bg

Galya Staneva, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biophysics
and Biomedical Engineering,
Bulgarian Academy of Sciences
Akad. G. Bonchev St, Bl. 21
1113 Sofia, Bulgaria

Е-mail: g_staneva@yahoo.com

Stefan Pankov, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biophysics
and Biomedical Engineering,
Bulgarian Academy of Sciences
Akad. G. Bonchev St, Bl. 21
1113 Sofia, Bulgaria

Е-mail: stefan.pankov@abv.bg

Nikolai Krastev, Department of Anatomy, Histology and Embryology Medical University – Sofia, Bulgaria

Mailing Address:
Department of Anatomy,
Histology and Embryology
Medical University – Sofia
1 St. Georgi Sofiiski Blvd
1431 Sofia, Bulgaria

E-mail: dr.krustev.dm@gmail.com

Tania Markovska, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biophysics
and Biomedical Engineering,
Bulgarian Academy of Sciences
Akad. G. Bonchev St, Bl. 21
1113 Sofia, Bulgaria

Е-mail: Markobska@abv.bg

Evgenia Vassileva, Clinic of Neurology, University Hospital Tsaritsa Yoanna – ISUL, Bulgaria

Mailing Address:
Clinic of Neurology,
University Hospital Tsaritsa Yoanna – ISUL
8 Byalo More St
1527 Sofia, Bulgaria

E-mail: e.vassilevva@gmail.com

Biliana Nikolova, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biophysics
and Biomedical Engineering,
Bulgarian Academy of Sciences
Akad. G. Bonchev St, Bl. 21
1113 Sofia, Bulgaria

Е-mail: nikolova@bio21.bas.bg

Dimo Krastev, Medical College “Y. Filaretova”, Medical University – Sofia, Bulgaria

Mailing Address:
Medical University – Sofia,
Medical College “Y. Filaretova”
3 Yordanka Filaretova St
1606 Sofia Bulgaria

E-mail: Dimo_krustev@mail.bg

Roumen Pankov, Faculty of Biology, Sofia University “St. Kliment Ohridski”, Bulgaria

Mailing Address:
Faculty of Biology,
Sofia University “St. Kliment Ohridski”
8 Dragan Tzankov Blvd
1164 Sofia, Bulgaria

E-mail: rpankov@biofac.uni-sofia.bg

Downloads

Published

30-09-2022

How to Cite

[1]
A. Momchilova, “Resveratrol Alters Sphingolipid Metabolism in ras-transformed 3T3 Fibroblasts”, C. R. Acad. Bulg. Sci., vol. 75, no. 9, pp. 1310–1316, Sep. 2022.

Issue

Section

Biology